CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-05 | TANG KEVIN C 10% owner | Purchase | +160,000 | $15.31 | $2.4M | 1,120,000 |
| 2020-11-05 | TANG KEVIN C 10% owner | Purchase | +77,133 | $14.22 | $1.1M | 1,197,133 |
| 2020-11-05 | TANG KEVIN C 10% owner | Purchase | +71,241 | $15.32 | $1.1M | 1,268,374 |
| 2020-11-05 | TANG KEVIN C 10% owner | Purchase | +171,626 | $23.79 | $4.1M | 1,440,000 |
| 2020-11-05 | TANG KEVIN C 10% owner | Purchase | +137,241 | $20.78 | $2.9M | 1,577,241 |
| 2020-11-05 | TANG KEVIN C 10% owner | Purchase | +8,482 | $20.94 | $178K | 1,585,723 |
| 2020-11-04 | TANG KEVIN C 10% owner | Purchase | +68,296 | $10.63 | $726K | 391,621 |
| 2020-11-04 | TANG KEVIN C 10% owner | Purchase | +88,379 | $13.11 | $1.2M | 480,000 |
| 2020-11-04 | TANG KEVIN C 10% owner | Purchase | +160,000 | $13.83 | $2.2M | 640,000 |
| 2020-11-04 | TANG KEVIN C 10% owner | Purchase | +99,854 | $13.65 | $1.4M | 739,854 |
| 2020-11-04 | TANG KEVIN C 10% owner | Purchase | +60,146 | $16.33 | $982K | 800,000 |
| 2020-11-04 | TANG KEVIN C 10% owner | Purchase | +160,000 | $16.84 | $2.7M | 960,000 |
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −2,695 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −1,928 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −3,128 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −2,407 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −2,407 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −4,814 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Returned to the company · Stock Option (right to buy) | −4,814 | 0 | ||
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Grant or award · Stock Option (right to buy) | +7,380 | 7,380 |
Page 14 of 27 · 523 trades